Cancer and Tumour Immunobiology

The tumour is an important aspect of cancer biology that contributes to tumour initiation, tumour progression and responses to therapy. Cells and molecules of the immune system is a fundamental component of the tumour microenvironment. Importantly, therapeutic strategies can harness the immune system to specifically target tumour cells and this is particularly appealing owing to the possibility of inducing tumour-specific immunological memory, which might cause long-lasting regression and prevent relapse in cancer patients. The composition and characteristics of the tumour microenvironment vary widely and are important in determining the anti-tumour immune response. 

Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer.

  • Anti-cancer/ Tumour immunity
  • Immunologic surveillance and Tumour immunity
  • Cancer immunotherapy & Neo antigens in cancer immunotherapy
  • Neutrophils and macrophages in cancer/Tumour
  • Tumour angiogenesis
  • Non-specific cancer immunotherapies and adjuvants
  • Insights for Immunotherapy
  • Chimeric antigen receptor (CAR) T-cell therapy

Related Conference of Cancer and Tumour Immunobiology

October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia

Cancer and Tumour Immunobiology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in